MabCure, Inc. (MBCI) est une société cotée en bourse dans le Énergie secteur, opérant dans le Solar secteur d'activité. Le siège social de l'entreprise est situé à White Plains, NY, United States. Le PDG actuel est Jehu Thomas Degerold Hand.
MBCI a date d'introduction en bourse 2007-12-05, 3 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $36.61K.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
